Completed PHASE1 INTERVENTIONAL 3-arm NCT00548444

T-Cell Turnover Following Vaccination With MVA85A

Measurement of Human T-Cell Turnover Following Vaccination With the Tuberculosis Vaccine MVA85A

Sponsor: St George's, University of London

Interventions Deuterated glucose infusion MVA85A

Updated 6 times since 2017 Last updated: Jan 15, 2010 Started: Oct 31, 2007 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00548444, this PHASE1 trial focuses on Tuberculosis and remains completed. Sponsored by St George's, University of London, it has been updated 6 times since 2007, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Sep 2020 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St George's, University of London
University of Oxford
Wellcome Trust

Data source: University of Oxford

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oxford, United Kingdom